Home
About
Overview
Sharing Data
ORCID
Help
History (5)
Acinetobacter
Arbaclofen in fragile X syndrome: results of phase 3 trials.
Generation and characterization of an immunogenic dendritic cell population.
Open-label pilot clinical trial of citicoline for fragile X-associated tremor/ataxia syndrome (FXTAS).
Scott, Cheryl
See All 5 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Arbaclofen in fragile X syndrome: results of phase 3 trials.
Arbaclofen in fragile X syndrome: results of phase 3 trials. J Neurodev Disord. 2017; 9:3.
View in:
PubMed
authors with profiles
Elizabeth M Berry-Kravis